Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00885469 · ClinicalTrials.gov registry record
PillCam® ESO 2 in Esophageal Pathologies
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 101
- Enrollment target
NCT00885469 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 101 participants.
The verdict
NCT00885469 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
Study Hypothesis: * PillCam™ ESO-2 will demonstrate equivalent accuracy parameters as compared to blinded esophagogastroduodenoscopy (EGD) in detecting suspected Barrett's esophagus, detecting and grading esophagitis. * PillCam™ ESO will demonstrate all safety parameters as compared to EGD * PillCam™ ESO-2 will demonstrate better patient's satisfaction as compared to EGD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00885469
The ClinicalTrials.gov registry entry for NCT00885469 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00885469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00885469 about?
NCT00885469 is a clinical study titled "PillCam® ESO 2 in Esophageal Pathologies". Study Hypothesis: * PillCam™ ESO-2 will demonstrate equivalent accuracy parameters as compared to blinded esophagogastroduodenoscopy (EGD) in detecting suspected Barrett's esophagus, detecting and grading esophagitis. * PillCam™ ESO will demonstrate all safety parameters as compared to EGD * PillCa...
What is the current status of trial NCT00885469?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2007-12. Estimated completion is 2009-04.
Who is sponsoring clinical trial NCT00885469?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.